Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
28.00
+0.91 (3.36%)
Jun 24, 2025, 4:00 PM - Market closed
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $193.61 million as of June 25, 2025. Its market cap has increased by 1,719.99% in one year.
Market Cap
193.61M
Enterprise Value
153.18M
1-Year Change
1,719.99%
Ranking
Category
Stock Price
$28.00
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $193.61M, an increase of 363.36%. That is a compound annual growth rate of 42.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 23, 2025 | 193.61M | -22.76% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.83B |
| Johnson & Johnson | 364.09B |
| AbbVie | 324.59B |
| Novo Nordisk | 309.67B |
| UnitedHealth Group | 272.76B |
| Abbott Laboratories | 231.85B |
| Novartis AG | 229.25B |
| AstraZeneca | 218.15B |